|
2018-02-22 |
2018-02-20 |
GV
Geplanter Verkauf
|
Swan Winifred L
SVP and General Counsel
|
3.500
-26.4%
24,48
85.680 USD
|
3.500
-26.4%
|
24,48
|
85.680 USD
|
|
|
2018-01-19 |
2018-01-16 |
GV
Geplanter Verkauf
|
Swan Winifred L
SVP and General Counsel
|
3.500
-25.4%
24,88
87.080 USD
|
3.500
-25.4%
|
24,88
|
87.080 USD
|
|
|
2017-12-21 |
2017-12-20 |
GV
Geplanter Verkauf
|
Swan Winifred L
SVP and General Counsel
|
3.500
-24.5%
25,35
88.725 USD
|
3.500
-24.5%
|
25,35
|
88.725 USD
|
|
|
2017-11-15 |
2017-11-15 |
GV
Geplanter Verkauf
|
Swan Winifred L
SVP and General Counsel
|
3.500
-23.7%
25,73
90.055 USD
|
3.500
-23.7%
|
25,73
|
90.055 USD
|
|
|
2017-10-23 |
2017-10-20 |
GV
Geplanter Verkauf
|
TOWSE MATTHEW W
SVP and Chief Financial Office
|
4.030
-14.2%
27,50
110.825 USD
|
4.030
-14.2%
|
27,50
|
110.825 USD
|
|
|
2017-10-23 |
2017-10-20 |
GV
Geplanter Verkauf
|
Swan Winifred L
SVP and General Counsel
|
3.500
-22.9%
27,50
96.250 USD
|
3.500
-22.9%
|
27,50
|
96.250 USD
|
|
|
2017-10-04 |
2017-10-04 |
GV
Geplanter Verkauf
|
Turk Joseph E Jr
President
|
1.000
-1.4%
27,56
27.560 USD
|
1.000
-1.4%
|
27,56
|
27.560 USD
|
|
|
2017-09-21 |
2017-09-20 |
GV
Geplanter Verkauf
|
Swan Winifred L
SVP and General Counsel
|
3.500
-22.2%
27,27
95.445 USD
|
3.500
-22.2%
|
27,27
|
95.445 USD
|
|
|
2017-09-21 |
2017-09-20 |
GV
Geplanter Verkauf
|
TOWSE MATTHEW W
SVP and Chief Financial Office
|
4.300
-15.0%
27,27
117.261 USD
|
4.300
-15.0%
|
27,27
|
117.261 USD
|
|
|
2017-09-05 |
2017-09-05 |
GV
Geplanter Verkauf
|
Turk Joseph E Jr
President
|
1.000
-1.3%
27,95
27.950 USD
|
1.000
-1.3%
|
27,95
|
27.950 USD
|
|
|
2017-08-23 |
2017-08-21 |
GV
Geplanter Verkauf
|
TOWSE MATTHEW W
SVP and Chief Financial Office
|
4.300
-15.0%
29,22
125.646 USD
|
4.300
-15.0%
|
29,22
|
125.646 USD
|
|
|
2017-08-15 |
2017-08-15 |
GV
Geplanter Verkauf
|
Swan Winifred L
SVP and General Counsel
|
3.500
-21.5%
29,21
102.235 USD
|
3.500
-21.5%
|
29,21
|
102.235 USD
|
|
|
2017-08-10 |
2017-08-10 |
GV
Geplanter Verkauf
|
Turk Joseph E Jr
President
|
1.000
-1.3%
29,26
29.260 USD
|
1.000
-1.3%
|
29,26
|
29.260 USD
|
|
|
2017-08-08 |
2017-08-07 |
GV
Geplanter Verkauf
|
Turk Joseph E Jr
President
|
18.000
-19.2%
29,63
533.340 USD
|
18.000
-19.2%
|
29,63
|
533.340 USD
|
|
|
2017-08-08 |
2017-08-07 |
GV
Geplanter Verkauf
|
Turk Joseph E Jr
President
|
6.000
-6.0%
29,66
177.960 USD
|
6.000
-6.0%
|
29,66
|
177.960 USD
|
|
|
2017-08-04 |
2017-08-03 |
GV
Geplanter Verkauf
|
Turk Joseph E Jr
President
|
7.000
-8.4%
22,98
160.860 USD
|
7.000
-8.4%
|
22,98
|
160.860 USD
|
|
|
2017-07-21 |
2017-07-20 |
GV
Geplanter Verkauf
|
Swan Winifred L
SVP and General Counsel
|
3.500
-20.9%
24,16
84.560 USD
|
3.500
-20.9%
|
24,16
|
84.560 USD
|
|
|
2017-07-21 |
2017-07-20 |
GV
Geplanter Verkauf
|
TOWSE MATTHEW W
SVP and Chief Financial Office
|
4.300
-15.0%
24,16
103.888 USD
|
4.300
-15.0%
|
24,16
|
103.888 USD
|
|
|
2017-07-07 |
2017-07-05 |
GV
Geplanter Verkauf
|
Turk Joseph E Jr
President
|
1.000
-1.3%
25,19
25.190 USD
|
1.000
-1.3%
|
25,19
|
25.190 USD
|
|
|
2017-06-21 |
2017-06-20 |
GV
Geplanter Verkauf
|
TOWSE MATTHEW W
SVP and Chief Financial Office
|
4.300
-14.5%
23,29
100.147 USD
|
4.300
-14.5%
|
23,29
|
100.147 USD
|
|
|
2017-06-16 |
2017-06-15 |
GV
Geplanter Verkauf
|
Swan Winifred L
SVP and General Counsel
|
3.500
-20.3%
23,14
80.990 USD
|
3.500
-20.3%
|
23,14
|
80.990 USD
|
|
|
2017-07-07 |
2017-06-14 |
GV
Geplanter Verkauf
|
Turk Joseph E Jr
President
|
1.000
-1.3%
23,74
23.740 USD
|
1.000
-1.3%
|
23,74
|
23.740 USD
|
|
|
2017-06-12 |
2017-06-08 |
GV
Geplanter Verkauf
|
Turk Joseph E Jr
President
|
2.250
-2.8%
23,59
53.078 USD
|
2.250
-2.8%
|
23,59
|
53.078 USD
|
|
|
2017-05-23 |
2017-05-22 |
GV
Geplanter Verkauf
|
TOWSE MATTHEW W
SVP and Chief Financial Office
|
4.300
-14.5%
21,36
91.848 USD
|
4.300
-14.5%
|
21,36
|
91.848 USD
|
|
|
2017-05-15 |
2017-05-15 |
GV
Geplanter Verkauf
|
Swan Winifred L
SVP and General Counsel
|
3.500
-19.7%
21,94
76.790 USD
|
3.500
-19.7%
|
21,94
|
76.790 USD
|
|
|
2017-05-11 |
2017-05-10 |
GV
Geplanter Verkauf
|
Turk Joseph E Jr
President
|
250
-0.3%
23,59
5.898 USD
|
250
-0.3%
|
23,59
|
5.898 USD
|
|
|
2017-05-04 |
2017-05-03 |
GV
Geplanter Verkauf
|
Turk Joseph E Jr
President
|
1.000
-1.3%
29,95
29.950 USD
|
1.000
-1.3%
|
29,95
|
29.950 USD
|
|
|
2017-04-21 |
2017-04-20 |
GV
Geplanter Verkauf
|
Burbank Jeffrey H
Chief Executive Officer
|
3.000
-0.3%
27,28
81.840 USD
|
3.000
-0.3%
|
27,28
|
81.840 USD
|
|
|
2017-04-20 |
2017-04-20 |
GV
Geplanter Verkauf
|
TOWSE MATTHEW W
SVP and Chief Financial Office
|
4.300
-14.5%
27,28
117.304 USD
|
4.300
-14.5%
|
27,28
|
117.304 USD
|
|
|
2017-04-20 |
2017-04-20 |
GV
Geplanter Verkauf
|
Swan Winifred L
SVP and General Counsel
|
3.500
-19.2%
27,28
95.480 USD
|
3.500
-19.2%
|
27,28
|
95.480 USD
|
|
|
2017-04-20 |
2017-04-19 |
GV
Geplanter Verkauf
|
Burbank Jeffrey H
Chief Executive Officer
|
3.000
-0.3%
26,65
79.950 USD
|
3.000
-0.3%
|
26,65
|
79.950 USD
|
|
|
2017-04-14 |
2017-04-13 |
GV
Geplanter Verkauf
|
Turk Joseph E Jr
President
|
1.000
-1.3%
26,10
26.100 USD
|
1.000
-1.3%
|
26,10
|
26.100 USD
|
|
|
2017-04-04 |
2017-04-03 |
GV
Geplanter Verkauf
|
Brown Robert S.
President, NxStage Kidney Care
|
14.397
-51.4%
26,60
382.960 USD
|
14.397
-51.4%
|
26,60
|
382.960 USD
|
|
|
2017-03-23 |
2017-03-22 |
GV
Geplanter Verkauf
|
Burbank Jeffrey H
Chief Executive Officer
|
3.000
-0.3%
27,42
82.260 USD
|
3.000
-0.3%
|
27,42
|
82.260 USD
|
|
|
2017-03-22 |
2017-03-21 |
GV
Geplanter Verkauf
|
Burbank Jeffrey H
Chief Executive Officer
|
3.000
-0.3%
27,72
83.160 USD
|
3.000
-0.3%
|
27,72
|
83.160 USD
|
|
|
2017-03-22 |
2017-03-20 |
GV
Geplanter Verkauf
|
Swan Winifred L
SVP and General Counsel
|
15.723
-50.7%
27,66
434.898 USD
|
15.723
-50.7%
|
27,66
|
434.898 USD
|
|
|
2017-03-22 |
2017-03-20 |
GV
Geplanter Verkauf
|
TOWSE MATTHEW W
SVP and Chief Financial Office
|
4.300
-14.5%
27,66
118.938 USD
|
4.300
-14.5%
|
27,66
|
118.938 USD
|
|
|
2017-03-16 |
2017-03-16 |
V
Verkauf
|
MOORE CRAIG W
|
1.000
-1.0%
27,93
27.930 USD
|
1.000
-1.0%
|
27,93
|
27.930 USD
|
|
|
2017-03-08 |
2017-03-08 |
GV
Geplanter Verkauf
|
Turk Joseph E Jr
President
|
1.000
-1.2%
27,53
27.530 USD
|
1.000
-1.2%
|
27,53
|
27.530 USD
|
|
|
2017-03-07 |
2017-03-07 |
GV
Geplanter Verkauf
|
Brown Robert S.
President, NxStage Kidney Care
|
20.000
-55.4%
27,75
555.000 USD
|
20.000
-55.4%
|
27,75
|
555.000 USD
|
|
|
2017-03-06 |
2017-03-06 |
GV
Geplanter Verkauf
|
Brown Robert S.
President, NxStage Kidney Care
|
6.390
-28.4%
28,01
178.984 USD
|
6.390
-28.4%
|
28,01
|
178.984 USD
|
|
|
2017-02-24 |
2017-02-23 |
GV
Geplanter Verkauf
|
Burbank Jeffrey H
Chief Executive Officer
|
7.500
-0.8%
28,97
217.275 USD
|
7.500
-0.8%
|
28,97
|
217.275 USD
|
|
|
2017-02-23 |
2017-02-22 |
GV
Geplanter Verkauf
|
Burbank Jeffrey H
Chief Executive Officer
|
7.500
-0.8%
29,01
217.575 USD
|
7.500
-0.8%
|
29,01
|
217.575 USD
|
|
|
2017-02-23 |
2017-02-21 |
GV
Geplanter Verkauf
|
TOWSE MATTHEW W
SVP and Chief Financial Office
|
4.300
-18.7%
29,26
125.818 USD
|
4.300
-18.7%
|
29,26
|
125.818 USD
|
|
|
2017-02-21 |
2017-02-17 |
GV
Geplanter Verkauf
|
Turk Joseph E Jr
President
|
6.000
-8.0%
29,66
177.960 USD
|
6.000
-8.0%
|
29,66
|
177.960 USD
|
|
|
2017-02-15 |
2017-02-15 |
GV
Geplanter Verkauf
|
Swan Winifred L
SVP and General Counsel
|
16.049
-60.5%
28,01
449.532 USD
|
16.049
-60.5%
|
28,01
|
449.532 USD
|
|
|
2017-02-15 |
2017-02-14 |
GV
Geplanter Verkauf
|
Brown Robert S.
President, NxStage Kidney Care
|
2.448
-12.4%
28,28
69.229 USD
|
2.448
-12.4%
|
28,28
|
69.229 USD
|
|
|
2017-02-13 |
2017-02-10 |
GV
Geplanter Verkauf
|
Turk Joseph E Jr
President
|
2.500
-3.5%
28,59
71.475 USD
|
2.500
-3.5%
|
28,59
|
71.475 USD
|
|
|
2017-02-13 |
2017-02-09 |
GV
Geplanter Verkauf
|
Turk Joseph E Jr
President
|
1.000
-1.4%
27,77
27.770 USD
|
1.000
-1.4%
|
27,77
|
27.770 USD
|
|
|
2017-02-08 |
2017-02-08 |
GV
Geplanter Verkauf
|
Brown Robert S.
President, NxStage Kidney Care
|
3.054
-13.4%
27,61
84.321 USD
|
3.054
-13.4%
|
27,61
|
84.321 USD
|
|
|
2017-02-07 |
2017-02-07 |
GV
Geplanter Verkauf
|
Brown Robert S.
President, NxStage Kidney Care
|
3.117
-12.0%
27,54
85.842 USD
|
3.117
-12.0%
|
27,54
|
85.842 USD
|
|
|
2017-02-06 |
2017-02-06 |
GV
Geplanter Verkauf
|
Brown Robert S.
President, NxStage Kidney Care
|
3.283
-11.2%
27,29
89.593 USD
|
3.283
-11.2%
|
27,29
|
89.593 USD
|
|
|
2017-02-06 |
2017-02-03 |
GV
Geplanter Verkauf
|
Brown Robert S.
President, NxStage Kidney Care
|
13.000
-30.8%
26,77
348.010 USD
|
13.000
-30.8%
|
26,77
|
348.010 USD
|
|
|
2017-02-02 |
2017-02-02 |
GV
Geplanter Verkauf
|
Brown Robert S.
President, NxStage Kidney Care
|
17.745
-37.8%
26,72
474.146 USD
|
17.745
-37.8%
|
26,72
|
474.146 USD
|
|
|
2017-02-02 |
2017-02-02 |
GV
Geplanter Verkauf
|
Turk Joseph E Jr
President
|
15.669
-18.2%
26,19
410.371 USD
|
15.669
-18.2%
|
26,19
|
410.371 USD
|
|
|
2017-02-02 |
2017-02-01 |
GV
Geplanter Verkauf
|
Brown Robert S.
President, NxStage Kidney Care
|
19.602
-36.6%
26,65
522.393 USD
|
19.602
-36.6%
|
26,65
|
522.393 USD
|
|
|
2017-01-26 |
2017-01-26 |
GV
Geplanter Verkauf
|
Brown Robert S.
President, NxStage Kidney Care
|
7.000
-14.7%
26,25
183.750 USD
|
7.000
-14.7%
|
26,25
|
183.750 USD
|
|
|
2017-01-26 |
2017-01-25 |
GV
Geplanter Verkauf
|
Brown Robert S.
President, NxStage Kidney Care
|
20.000
-33.0%
26,13
522.600 USD
|
20.000
-33.0%
|
26,13
|
522.600 USD
|
|
|
2017-01-26 |
2017-01-24 |
GV
Geplanter Verkauf
|
Brown Robert S.
President, NxStage Kidney Care
|
15.000
-27.0%
25,86
387.900 USD
|
15.000
-27.0%
|
25,86
|
387.900 USD
|
|
|
2017-01-23 |
2017-01-23 |
GV
Geplanter Verkauf
|
Brown Robert S.
President, NxStage Kidney Care
|
15.000
-27.0%
25,74
386.100 USD
|
15.000
-27.0%
|
25,74
|
386.100 USD
|
|
|
2017-01-23 |
2017-01-20 |
GV
Geplanter Verkauf
|
Swan Winifred L
SVP and General Counsel
|
3.500
-24.2%
26,19
91.665 USD
|
3.500
-24.2%
|
26,19
|
91.665 USD
|
|
|
2017-01-23 |
2017-01-20 |
GV
Geplanter Verkauf
|
TOWSE MATTHEW W
SVP and Chief Financial Office
|
4.300
-18.7%
26,19
112.617 USD
|
4.300
-18.7%
|
26,19
|
112.617 USD
|
|
|
2017-01-23 |
2017-01-19 |
GV
Geplanter Verkauf
|
Brown Robert S.
President, NxStage Kidney Care
|
200
-0.5%
27,91
5.582 USD
|
200
-0.5%
|
27,91
|
5.582 USD
|
|
|
2017-01-23 |
2017-01-19 |
GV
Geplanter Verkauf
|
Brown Robert S.
President, NxStage Kidney Care
|
6.415
-13.6%
27,23
174.680 USD
|
6.415
-13.6%
|
27,23
|
174.680 USD
|
|
|
2017-01-18 |
2017-01-18 |
GV
Geplanter Verkauf
|
Brown Robert S.
President, NxStage Kidney Care
|
8.183
-14.8%
27,58
225.687 USD
|
8.183
-14.8%
|
27,58
|
225.687 USD
|
|
|
2017-01-18 |
2017-01-18 |
GV
Geplanter Verkauf
|
Burbank Jeffrey H
Chief Executive Officer
|
7.500
-0.9%
27,63
207.225 USD
|
7.500
-0.9%
|
27,63
|
207.225 USD
|
|
|
2017-01-17 |
2017-01-17 |
GV
Geplanter Verkauf
|
Brown Robert S.
President, NxStage Kidney Care
|
10.805
-16.3%
27,72
299.515 USD
|
10.805
-16.3%
|
27,72
|
299.515 USD
|
|
|
2017-01-17 |
2017-01-17 |
GV
Geplanter Verkauf
|
Burbank Jeffrey H
Chief Executive Officer
|
7.500
-0.8%
27,52
206.400 USD
|
7.500
-0.8%
|
27,52
|
206.400 USD
|
|
|
2017-01-17 |
2017-01-13 |
GV
Geplanter Verkauf
|
Turk Joseph E Jr
President
|
7.500
-9.6%
28,00
210.000 USD
|
7.500
-9.6%
|
28,00
|
210.000 USD
|
|
|
2017-01-11 |
2017-01-11 |
GV
Geplanter Verkauf
|
Turk Joseph E Jr
President
|
1.000
-1.3%
27,77
27.770 USD
|
1.000
-1.3%
|
27,77
|
27.770 USD
|
|
|
2016-12-20 |
2016-12-20 |
GV
Geplanter Verkauf
|
TOWSE MATTHEW W
SVP and Chief Financial Office
Führungsperson
|
4.300
-18.7%
25,55
109.865 USD
|
4.300
-18.7%
|
25,55
|
109.865 USD
|
|
|
2016-12-16 |
2016-12-15 |
GV
Geplanter Verkauf
|
Swan Winifred L
SVP and General Counsel
Führungsperson
|
3.500
-23.4%
25,91
90.685 USD
|
3.500
-23.4%
|
25,91
|
90.685 USD
|
|
|
2016-12-14 |
2016-12-14 |
GV
Geplanter Verkauf
|
Burbank Jeffrey H
Chief Executive Officer
Geschäftsführender Verwaltungsratsmitglied
|
7.500
-0.8%
25,68
192.600 USD
|
7.500
-0.8%
|
25,68
|
192.600 USD
|
|
|
2016-12-13 |
2016-12-13 |
GV
Geplanter Verkauf
|
Turk Joseph E Jr
President
Führungsperson
|
1.000
-1.3%
25,42
25.420 USD
|
1.000
-1.3%
|
25,42
|
25.420 USD
|
|
|
2016-12-13 |
2016-12-13 |
GV
Geplanter Verkauf
|
Burbank Jeffrey H
Chief Executive Officer
Geschäftsführender Verwaltungsratsmitglied
|
7.500
-0.8%
25,42
190.650 USD
|
7.500
-0.8%
|
25,42
|
190.650 USD
|
|
